Tysuna^®

Sunitinib

Product Information

Proprietary Name: Tysuna®
Generic Name: Sunitinib
Dosage Form: Hard Gelatin Capsule
Strengths: 12.5 mg, 25 mg, 50 mg
Indications: Gastrointestinal Stromal Tumor, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumors

Download Leaflet

Oncology

Tysuna®

Sunitinib is indicated for the treatment of gastrointestinal stromal tumor, renal cell carcinoma, and pancreatic neuroendocrine tumors.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.